Skip to main content

Advertisement

Log in

Analyzing Preeclampsia as the Tip of the Iceberg Represented by Women with Long-Term Cardiovascular Disease, Atherosclerosis, and Inflammation

  • Evidence-Based Medicine, Clinical Trials and Their Interpretations (L. Roever, Section Editor)
  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Cardiovascular and endothelial dysfunction is recognized nowadays as an important etiological factor contributing to the development of hypertensive disorders of pregnancy.

Recent Findings

Preeclampsia is considered a specific disease of pregnancy, but recent theories suggest that women suffering from the condition have greater propensity to develop atherosclerosis, heart disease, and stroke over the years.

Summary

It is possible that transient but severe endothelial dysfunction observed in preeclampsia potentiates a cascade of events that progresses to atherosclerosis. Preeclampsia offers a unique window of opportunity to identify maternal endothelial dysfunction and pre-existing cardiovascular disease. The placenta is closely involved in the onset of preeclampsia, but endothelial and cardiac vascular factors also play important causal roles in the development of hypertension during pregnancy. According to the data presented, it is clear that preeclampsia selects a group at high risk of development of atherosclerosis and at increased cardiovascular risk, as well as of stroke, in the decades following childbirth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Bell MJ. A historical overview of preeclampsia-eclampsia. J Obstet Gynecol Neonatal Nurs. 2010 September;39(5):510–8.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Ong S. Pre-eclampsia: a historical perspective. In: Baker PN, Kingdom JCP, editors. Pre-eclampsia: current perspectives on management. New York: The Parthenon Publishing Group; 2004. p. 15–24.

    Google Scholar 

  3. Hidaka A, Nakamoto O. Historical perspective of preeclampsia from the viewpoint of pathogenesis: ancient times to mid-20th century. Hypertens Res Pregnancy. 2014;2:40–6.

    Article  Google Scholar 

  4. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(05):649–58.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta. 2009;30(Suppl A):S32–7. https://doi.org/10.1016/j.placenta.2008.11.009.

    Article  CAS  PubMed  Google Scholar 

  6. Quinn MJ. Pre-eclampsia - The “uterine reinnervation” view. Med Hypotheses. 2014;83(05):575–9.

    Article  CAS  PubMed  Google Scholar 

  7. Abou El Hassan M, Diamandis EP, Karumanchi SA, Shennan AH, Taylor RN. Preeclampsia: an old disease with new tools for better diagnosis and risk management. Clin Chem. 2015;61(05):694–8.

    Article  CAS  PubMed  Google Scholar 

  8. Tanrikulu L, Naraghi R, Ernst V, et al. Neurovascular compression of medulla oblongata - association for gestation-induced hypertension. Med Hypotheses. 2015;84:605–10.

    Article  Google Scholar 

  9. Gathiram P, Moodley J. Pre-eclampsia: its pathogenesis and pathophysiolgy. Cardiovasc J Afr. 2016;27(02):71–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Brew O, Sullivan MHF, Woodman A. Comparison of normal and pre-eclamptic placental gene expression: a systematic review with meta-analysis. PLoS One. 2016 Aug 25;11(08):e0161504. https://doi.org/10.1371/journal.pone.0161504. eCollection 2016.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Cunningham GF, Leveno KJ, Bloom SL, et al. Williams Obstetrics. 24th ed. New York: McGraw-Hill Education; 2014.

    Google Scholar 

  12. Ngene NC, Moodley J. Role of angiogenic factors in the pathogenesis and management of pre-eclampsia. Int J Gynaecol Obstet. 2018;41(01):5–13.

    Article  CAS  Google Scholar 

  13. Kim J-Y, Kim YM. Acute Atherosis of the uterine spiral arteries: Clinicopathologic implications. J Pathol Transl Med; 2015;49:462–71.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Muijsers HEC, Roeleveld N, van der Heijden OWH, Maas AHEM. Consider preeclampsia as a first cardiovascular event. Curr Cardiovasc Risk Rep. 2019;13:21.

    Article  Google Scholar 

  15. Bellamy L, Casas J-P, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007:335–974.

  16. •• Kalafat E, Thilaganathan B. Cardiovascular origins of preeclampsia. Curr Opin Obstet Gynecol. 2017;29(6):383–9. Considering preeclampsia to be a cardiovascular syndrome.

    Article  PubMed  Google Scholar 

  17. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365(9461):785–99.

    Article  PubMed  Google Scholar 

  18. Ventura SJ, Menacker CS, Births F. final data for 1999. In: National Vital Statistics Report, vol. 49; 2001.

    Google Scholar 

  19. Silva JMP, Fonseca SC, Dias MAB, Izzo AS, Teixeira GP, Belfort PP. Concepts, prevalence and characteristics of severe maternal morbidity and near miss in Brazil: a systematic review. Rev Bras Saude Mater Infant; 2018;18(1).

    Article  Google Scholar 

  20. Ramos JGL, Sass N, Costa SHM. Preeclampsia. Rev Bras Ginecol Obstet. 2017;39:496–512.

    Article  PubMed  Google Scholar 

  21. Behrens I, Basit S, Melbye M, Lykke JA, Wohlfahrt J, Bundgaard H, et al. Risk of post-pregnancy hypertension in women with a history of hypertensive disorders of pregnancy: nationwide cohort study. BMJ. 2017;358:j3078.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Grand’Maison S, Pilote L, Schlosser K, Stewart DJ, Okano M, Dayan N. Clinical features and outcomes of acute coronary syndrome in women with previous pregnancy complications. Can J Cardiol. 2017;33:1683–92.

    Article  PubMed  Google Scholar 

  23. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(05):1122–31.

    Article  Google Scholar 

  24. Brown MA, Magee LA, Kenny LC, et al. International Society for the Study of hypertension in pregnancy (ISSHP). Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(01):24–43.

    Article  CAS  PubMed  Google Scholar 

  25. Peraçoli JC, Borges VTM, et al. Pre-eclampsia/Eclampsia. Rev Bras Ginecol Obstet. 2019;41(5):318–32.

    Article  PubMed  Google Scholar 

  26. von Dadelzen P, Payne B, Li J, et al. Prediction of adverse maternal outcomes in preeclampsia: development and validation of the fullPIERS model. Lancet. 2011;377:219–27.

    Article  Google Scholar 

  27. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592–4.

    Article  CAS  PubMed  Google Scholar 

  28. Romero R, Chaiworapongsa T. Preeclampsia: a link between trophoblast dysregulation and an antiangiogenic state. J Clin Invest. 2013;123:2775–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Rana S, Lemoine E, Granger J, Karumanchi AS. Preeclampsia. Pathophysiology, challenges, and perspectives. Circ Res. 2019;124:1094–112.

    Article  CAS  PubMed  Google Scholar 

  30. Herraiz I, Llurba E, Verlohren S, Galindo A. Update on the diagnosis and prognosis of preeclampsia with the aid of the sFlt-1/ PlGF ratio in singleton pregnancies. Fetal Diagn Ther. 2018;43(2):81–9.

    Article  PubMed  Google Scholar 

  31. Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension. 2008 Nov;52(5):873–80.

    Article  CAS  PubMed  Google Scholar 

  32. Castleman JS, Ganapathy R, Taki F, Lip GY, Steeds RP, Kotecha D. Echocardiographic structure and function in hypertensive disorders of pregnancy: a systematic review. Circ Cardiovasc Imaging. 2016;9(9).

  33. •• Melchiorre K, Sharma R, Thilaganathan B. Maternal cardiovascular function in normal pregnancy: evidence of maladaptationormal to chronic volume overload. Hypertension. 2016;67:754–62. Longitudinal study that demonstraded cardiac dysfunction in a small but significant group of women at term.

    Article  CAS  PubMed  Google Scholar 

  34. Timokhina E, Kuzmina T, Strizhakov A, Pitskhelauri E, Ignatko I, Belousova V. Maternal cardiac function after normal delivery, preeclampsia, and eclampsia: a prospective study. J Pregnancy. 2019;2019:8.

    Article  Google Scholar 

  35. Simmons LA, Gillin AG, Jeremy RW. Structural and functional changes in left ventricle during normotensive and preeclamptic pregnancy. Am J Physiol Heart Circ Physiol. 2002 Oct;283(4):H1627–33.

    Article  CAS  PubMed  Google Scholar 

  36. Alves Borges JH, Goes DA, de Araújo LB, Dos Santos MC, Debs Diniz AL. Prospective study of the hemodynamic behavior of ophthalmic arteries in postpartum preeclamptic women: a doppler evaluation. Hypertens Pregnancy. 2016;35(1):100–11.

    Article  CAS  PubMed  Google Scholar 

  37. Diniz AL, Moron AF, dos Santos MC, Sass N, Pires CR, Debs CL. Ophthalmic artery Doppler as a measure of severe pre-eclampsia. Int J Gynaecol Obstet. 2008 Mar;100(3):216–20.

    Article  CAS  PubMed  Google Scholar 

  38. Maruyoshi H, Kojima S, Kojima S, Nagayoshi Y, Horibata Y, Kaikita K, et al. Waveform of ophthalmic artery Doppler flow predicts the severity of systemic atherosclerosis. Circ J. 2010 Jun;74(6):1251–6.

    Article  PubMed  Google Scholar 

  39. Koelwyn, Graeme & Currie, Katharine & Macdonald, Maureen & Eves, Neil. (2012). Ultrasonography and tonometry for the assessment of human arterial stiffness. https://doi.org/10.5772/39193. Available from: https://www.intechopen.com/books/applied-aspects-of-ultrasonography-in-humans/ultrasonography-and-tonometry-for-the-assessment-of-human-arterial-stiffness.

    Google Scholar 

  40. Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension. 2005;46(6).

    Article  CAS  PubMed  Google Scholar 

  41. Amaral LM, Cunningham MW Jr, Cornelius DC, LaMarca B. Preeclampsia: long-term consequences for vascular health. Vasc Health Risk Manag. 2015;15:11–4.

    Google Scholar 

  42. Çintesun E, Incesu Çintesun FN, Ezveci H, Akyürek F, Çelik Ç. Systemic inflammatory response markers in preeclampsia. J Lab & Physicians. 2018;10(3):316–9.

  43. Pant V, Yadav BK, Sharma J. A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia. BMC Pregnancy Childbirth. 2019;19(1):266.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  44. Arun Jeyabalan A, Powers RW, Durica AR, Harger G, Roberts JM, Ness RB. Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia. Am J Hypertens. 2008;21(8):943–7.

    Article  PubMed  CAS  Google Scholar 

  45. Paes MMBM, Diniz ALD. Chronic perfusion changes and reduction in preeclampsia incidence in pregnant smokers: an ophthalmic artery Doppler study. J Matern Fetalx Neonatal Med. 2015;28(17):2074–9.

    Article  Google Scholar 

  46. Bellamy L, Casas J-P, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Rangaswami J, Naranjo M, McCullough PA. Preeclampsia as a form of type 5 cardiorenal syndrome: an underrecognized entity in women’s cardiovascular health. Cardiorenal Med. 2018;8(2):160–72.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Kessous R, Shoham-Vardi I, Pariente G, Sergienko R, Sheiner E. Long-term maternal atherosclerotic morbidity in women with pre-eclampsia. Heart. 2015;101(6):442–6.

    Article  PubMed  Google Scholar 

  49. Christensen M, Kronborg CS, Carlsen RK, et al. Early gestational age at preeclampsia onset is associated with subclinical atherosclerosis 12 years after delivery. Acta Obstet Gynecol Scand. 2017 Sep;96(9):1084–92.

    Article  PubMed  Google Scholar 

  50. • Milic NM, Milin-Lazovic J, Weissgerber TL, Trajkovic G, White WM, Garovic VD. Preclinical atherosclerosis at the time of preeclamptic pregnancy and up to 10 years postpartum: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2017;49(1):110–5. Atherosclerotic load is present at the time of preeclampsia and may be one mechanism associated with preeclampsia.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Crandon AJ, Isherwood DM. Effect of aspirin on incidence of pre-eclampsia. Lancet. 1979;1:1356.

    Article  CAS  PubMed  Google Scholar 

  52. Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377(7):613–22.

    Article  CAS  PubMed  Google Scholar 

  53. Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2018;218(3):287–93.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Angélica Lemos Debs Diniz.

Ethics declarations

Conflict of Interest

Angélica Lemos Debs Diniz, Maria Marta Bini Martins Paes, and Aline Debs Diniz each declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki Declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Evidence-Based Medicine, Clinical Trials and Their Interpretations

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Diniz, A.L.D., Paes, M.M.B.M. & Diniz, A.D. Analyzing Preeclampsia as the Tip of the Iceberg Represented by Women with Long-Term Cardiovascular Disease, Atherosclerosis, and Inflammation. Curr Atheroscler Rep 22, 13 (2020). https://doi.org/10.1007/s11883-020-0830-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11883-020-0830-6

Keywords

Navigation